Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Estudo de viabilidade e ensaio piloto híbrido de implementação de eficácia para a prevenção universal de transtornos mentais perinatais maternos como prática de rotina normalizada (piloto e-Perinatal)

18 de setembro de 2026 atualizado por: Emma Motrico, University of Seville

Prevenção universal de transtornos mentais perinatais maternos e sua implementação como prática de rotina normalizada (e-Perinatal): ensaio piloto randomizado de controle (WP2)

This study is part of the e-Perinatal project, funded by the European Research Council. This research project will follow the first three phases recommended by the Medical Research Council (MRC) framework for the development and evaluation of complex interventions (Skivington et al., 2021).

The primary aim is to evaluate the feasibility and acceptability of implementing an innovative, personalized mobile health (mHealth) intervention designed for the universal prevention of perinatal mental disorders. Using a pilot, two-arm, cluster-randomized hybrid type 1 clinical trial, the study will assess key implementation outcomes and preliminary effectiveness indicators. The findings will inform the design of a future large clinical trial, intending to evaluate the effectiveness, cost-effectiveness, and implementation of the intervention as part of maternal care.

Visão geral do estudo

Descrição detalhada

This pilot clinical study investigates the feasibility, acceptability, and preliminary implementation and effectiveness of the e-Perinatal app, an innovative, personalized mobile health (mHealth) intervention designed for the universal prevention of perinatal mental disorders. The study will be conducted as a two-arm, cluster-randomized, hybrid type 1 trial within routine maternal care settings in primary healthcare centers in Andalusia, Spain. Participants will include pregnant and postpartum women (up to five months postpartum) and their partners. Primary healthcare centers will be randomized to either the intervention or control arm.

The primary objective is to evaluate the feasibility of integrating the e-Perinatal app into routine maternal care. Secondary objectives include assessing the acceptability of the intervention among women, partners, and healthcare professionals and exploring preliminary effectiveness outcomes, such as the incidence of perinatal depression and anxiety in women, changes in depressive and anxiety symptoms in both women and their partners, and potential impacts on infant health and development.

The study hypothesizes that the e-Perinatal intervention will be feasible and acceptable for pregnant and postpartum women, their partners, and healthcare professionals involved in routine maternal care.

Participants will be recruited from primary healthcare centres and allocated by cluster randomization to either the intervention group, which will receive the e-Perinatal app along with standard maternal care, or the control group, which will receive standard maternal care and monthly psychoeducational emails.

Tipo de estudo

Intervencional

Inscrição (Real)

96

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • Seville
      • Mairena del Aljarafe, Seville, Espanha, 41927
        • Primary Health Care Center Mairena del Aljarafe - Ciudad Expo

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos e mais velhos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion criteria for mothers:

  • Must receive an invitation to participate from a healthcare professional at one of the participating primary healthcare centers
  • Must be pregnant for at least 16 weeks or have given birth within the last 5 months at the time of enrollment
  • Must be at least 18 years old
  • Must have access to a mobile phone and internet connection
  • Must be able to read, write, and understand Spanish
  • Must have a personal email account

Inclusion criteria for partners (or significant others):

  • Must receive an invitation to participate from a woman already enrolled in the study
  • Must be at least 18 years old
  • Must have access to a mobile phone and internet connection
  • Must be able to read, write, and understand Spanish
  • Must have a personal email account

Exclusion criteria for mothers:

  • Meet diagnostic criteria for anxiety or depression, as determined by a structured clinical interview
  • Be on a waiting list or currently receiving psychological or pharmacological treatment for any mental health or substance use condition

Exclusion criteria for partners (or significant others):

  • There are no exclusion criteria for partners

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Prevenção
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Solteiro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Grupo de intervenção

The e-Perinatal intervention combines a personalized mobile health (mHealth) app with targeted training for healthcare professionals to support perinatal mental health within routine maternal care. Participants allocated to the intervention arm will use the app for a period of two months. The app offers psychoeducational content, video-guided physical activities, mindfulness exercises, mood-tracking tools, personalized recommendations through a rule-based algorithm, and social-community features. Healthcare professionals assigned to the intervention arm receive specialized training to integrate the app into their daily practice, enhancing their ability to promote and support mental health during the perinatal period.

Comparador Ativo: Grupo de controle

Standard maternal care as routinely provided by the Andalusian public healthcare system (Spain). This includes scheduled visits with midwives, nurses, and pediatrician for maternal and infant health monitoring, as well as access to childbirth education programmes. Participants also receive monthly psychoeducational emails (two months) containing general information on perinatal mental health, pregnancy, and infant development. Healthcare professionals in this arm do not receive specialized training in perinatal mental health or in the use of digital interventions, and participants do not have access to the e-Perinatal app.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Feasibility of the intervention
Prazo: Measured at baseline and postintervention (2 months after baseline)

Calculation of participation rate, recruitment rate, and retention rate (follow-up rate) at all assessment points. Assessment method: Registration and follow-up records.

Measured at baseline and postintervention (2 months after baseline)
Early acceptability
Prazo: Measured at enrollment

Number of eligible women and partners who agree to participate. Assessment method: Consent forms.

Measured at enrollment
Final acceptability
Prazo: Measured at postintervention (2 months after baseline)

Evaluation of how appropriate, satisfactory, and feasible the intervention is after its implementation. Assessment method: Surveys and semi-structured interviews based on the Normalization Process Theory.

Measured at postintervention (2 months after baseline)

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Adoption
Prazo: Measured before recruitment

Proportion of Primary Health Care (PHC) professionals who express their willingness to participate in the study among the total of potential professionals prior to the start of the intervention. Assessment method: Registration records.

Measured before recruitment
Fidelity
Prazo: Measured at postintervention (2 months after baseline)

Measures adherence to the study protocol by PHC professionals. Assessment method: Surveys.

Measured at postintervention (2 months after baseline)
Early appropriateness
Prazo: Measured at enrollment

Number of eligible women and number of partners invited to participate by women. Assessment method: Consent forms and recruitment records.

Measured at enrollment
Final appropriateness
Prazo: Measured at postintervention (2 months after baseline)

Suitability and relevance of the intervention for the target population and context. Assessment method: Semi-structured interviews based on the Normalization Process Theory.

Measured at postintervention (2 months after baseline)
Cumulative incidence of maternal perinatal depression and maternal perinatal anxiety
Prazo: Measured at enrollment and postintervention (2 months after baseline)

Measurement of the incidence of maternal perinatal depression and anxiety. Assessment method: The Mini International Neuropsychiatric Interview (MINI).

Measured at enrollment and postintervention (2 months after baseline)
Depressive symptoms
Prazo: Measured at enrollment, postintervention (2 months after baseline), and follow-up (1 month after postintervention)

Changes in depressive symptoms. Assessment method: The Edinburgh Postnatal Depression Scale (EPDS), a 10-item self-report measure. Each item is scored from 0 to 3, with higher scores indicating more severe depressive symptoms.

Measured at enrollment, postintervention (2 months after baseline), and follow-up (1 month after postintervention)
Anxiety symptoms
Prazo: Measured at enrollment, postintervention (2 months after baseline), and follow-up (1 month after postintervention)

Changes in anxiety symptoms. Assessment method: The General Anxiety Questionnaire (GAD-7), a 7-item self-report measure. Each item is scored from 0 to 3, with higher scores indicating more severe anxiety symptoms.

Measured at enrollment, postintervention (2 months after baseline), and follow-up (1 month after postintervention)
Postnatal post-traumatic stress
Prazo: Measured at baseline

Presence of post-traumatic stress symptoms and clinical disorder in women or their partners after childbirth. Assessment method: Assessed using City Birth Trauma Scale (City-BiTS), a 31-item self-report measure. Some items are scored from 0 to 3 and others from 0 to 2, with higher scores indicating greater severity of postnatal post-traumatic stress.

Measured at baseline
Well-being
Prazo: Measured at baseline, postintervention (2 months after baseline), and follow-up (1 month after postintervention)

Changes in subjective well-being. Assessment method: The Well-Being Index (WHO-5), a 5-item self-report measure. Each item is scored from 0 to 5, with higher scores indicating better subjective well-being.

Measured at baseline, postintervention (2 months after baseline), and follow-up (1 month after postintervention)

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
Organizational readiness for implementing change
Prazo: Measured before recruitment

Organization's readiness for implementing changes in usual care. Assessment method: The Organizational Readiness Implementing Change (ORIC), a 12-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating greater readiness for implementing change.

Measured before recruitment
App quality
Prazo: Measured at postintervention (2 months after baseline)

Objective and subjective quality, and the perceived impact of the application. Assessment method: The User Version of the Mobile Application Rating Scale (u-MARS), a 26-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating better app quality.

Measured at postintervention (2 months after baseline)
Implementation process
Prazo: Measured at postintervention (2 months after baseline)

App implementation process from the perspective of healthcare professionals involved in implementing complex interventions. Assessment method: The Normalization Measure Development Questionnaire (NoMAD), a 20-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating more effective implementation processes.

Measured at postintervention (2 months after baseline)
Barriers and facilitators
Prazo: Measured at postintervention (2 months after baseline)

Identifies barriers and facilitators impacting the integration of the intervention into routine healthcare, drawing from the experiences of users and healthcare professionals. Assessment method: Semi-structured interviews following the Normalization Process Theory (NPT) framework

Measured at postintervention (2 months after baseline)
PHC characteristics
Prazo: Measured before recruitment

Size of the population where the PHC is located and number of PHC professionals. Assessment method: Questionnaire developed by the research team

Measured before recruitment
Reasons for dropout
Prazo: Measured at postintervention (2 months after baseline)

Number and reasons (e.g., experienced miscarriage or stillbirth, lack of engagement with the app) for dropout among women and their partners. Assessment method: Records and semi structured interviews.

Measured at postintervention (2 months after baseline)
Antenatal and postnatal risks
Prazo: Measured at baseline

Measures both antenatal and postnatal risk factors. Assessment method: The Antenatal Risk Questionnaire (ANRQ-R), a 11-item self-report measure. Some items are scored from 1 to 5 and others are scored on categorical scale, with higher scores indicating greater risk.

Measured at baseline
Maternal antenatal attachment
Prazo: Measured at baseline

Measures the level of maternal antenatal attachment to the baby. Assessment method: The Maternal Antenatal Attachment Scale (MAAS), a 19-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating stronger maternal antenatal attachment.

Measured at baseline
Paternal antenatal attachment
Prazo: Measured at baseline

Measures the level of paternal antenatal attachment to the baby. Assessment method: The Paternal Antenatal Attachment Scale (PAAS), a 16-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating stronger paternal antenatal attachment.

Measured at baseline
Maternal postnatal attachment
Prazo: Measured at baseline

Measures the level of maternal postnatal attachment to the baby. Assessment method: The Maternal Postnatal Attachment Scale (MPAS), a 19-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating stronger maternal postnatal attachment.

Measured at baseline
Paternal postnatal attachment
Prazo: Measured at baseline

Measures the level of postnatal attachment to the baby in both mothers and fathers. Assessment method: The Paternal Postnatal Attachment Scale (PPAS), a 19-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating stronger paternal postnatal attachment.

Measured at baseline
Infant temperament
Prazo: Measured at baseline

Measures various aspect of infant temperament. Assessment method: The Infant Behavior Questionnaire-Revised Short Form (IBQ-R SF), a 37-item self-report measure. Each item is scored from 1 to 7, with higher scores indicating a higher frequency of the specified temperament behavior.

Measured at baseline
Coparenting dynamics
Prazo: Measured at baseline

Measures the dynamics of coparenting relationships. Assessment method: The Coparenting Relationship Scale (CRS), a 14-item self-report measure. Each item is scored from 0 to 6, with higher scores indicating more positive coparenting dynamics.

Measured at baseline
Parental role perception
Prazo: Measured at baseline

Measures parents' perception of their competence in the parental role. Assessment method: The Parental Sense of Competence scale (PSOC), a 21-item self-report measure. Each item is scored from 1 to 6, with higher scores indicating a stronger sense of parental competence.

Measured at baseline
Infant development
Prazo: Measured at baseline

Measures various developmental milestones in infants.

Measured at baseline
Partnership quality
Prazo: Measured at baseline

Measures the quality of the marital or partnership relationship. Assessment method: The Quality of Marriage Index (QMI), a 6-item self-report measure. Some items are scored from 1 to 7 and others from 1 to 10, with higher scores indicating better relationship quality.

Measured at baseline
Sleep quality
Prazo: Measured at baseline

Measures the quality of sleep among participants. Assessment method: The Pittsburgh Sleep Quality Index (PSQI), a 19-item self-report measure. Some items are scored from 0 to 3 and some on a categorical scale, with higher scores indicating poorer sleep quality.

Measured at baseline
Life quality
Prazo: Measured at baseline

Measures the overall quality of life. Assessment method: The European Quality of Life-5 Dimensions-5 Levels (EuroQol-5D-5L), a 5-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating worse quality of life.

Measured at baseline
Maternal physical activity levels
Prazo: Measured at baseline

Measures physical activity levels in pregnant women and mothers. Assessment method: The Pregnancy Physical Activity Questionnaire (PPAQ), a 33-item self-report measure. Each item is scored from 0 to 5, with higher scores indicating higher levels of physical activity.

Measured at baseline
Paternal physical activity levels
Prazo: Measured at baseline

Measures physical activity levels in fathers. Assessment method: The International Physical Activity Questionnaire (IPAQ), a 7-item self-report measure. Each item is scored on a categorical scale, with higher scores indicating higher levels of physical activity.

Measured at baseline
Physical condition
Prazo: Measured at baseline

Measures overall physical condition and the main components (i.e., cardiorespiratory fitness, muscular strength, speed-agility, and flexibility) in pregnant women and mothers. Assessment method: The International FItness Scale (IFIS), a 5-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating better physical condition.

Measured at baseline
Mood state
Prazo: Measured at baseline

Measures positive and negative affect states. Assessment method: The Positive and Negative Affect Schedule (PANAS), a 20-item self-report measure. Each item is scored from 1 to 7, with higher scores indicating a higher frequency of the specified temperament behavior.

Measured at baseline
Basic psychological needs
Prazo: Measured at baseline

Measures the satisfaction and frustration of basic psychological needs. Assessment method: The Basic Psychological Need Satisfaction and Frustration Scale - Short Form (BPNSFS), a 12-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating a higher need satisfaction (i.e., need satisfaction subscale) or a higher need frustration (i.e., need frustration subscale).

Measured at baseline
Economic data
Prazo: Measured at postintervention (2 months after baseline)

Measures healthcare service utilization and sick leave days over the previous year among participating women.

Assessment method: a post hoc semi-structured interview that collects information on emergency visits, hospital admissions, primary care visits (e.g., nurse, midwife, social worker), secondary care visits, and consultations with specialists.

Measured at postintervention (2 months after baseline)

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Links úteis

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

2 de maio de 2025

Conclusão Primária (Real)

11 de novembro de 2025

Conclusão do estudo (Real)

31 de janeiro de 2026

Datas de inscrição no estudo

Enviado pela primeira vez

8 de outubro de 2024

Enviado pela primeira vez que atendeu aos critérios de CQ

11 de outubro de 2024

Primeira postagem (Real)

15 de outubro de 2024

Atualizações de registro de estudo

Última Atualização Postada (Real)

23 de setembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

18 de setembro de 2026

Última verificação

1 de setembro de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • SICEIA-2024-001659
  • 101042139 (Número de outro subsídio/financiamento: European Research Council (ERC))

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever